Clin2
NCT07728487Likely a fitRecruiting

AT-587 safety study in healthy volunteers

Hepatitis E

Part of Digestive system, Infections clinical trials.

This trial tests a new medication called AT-587 in healthy people to see if it is safe and how the body processes it. You may help by participating if you are in good health and meet the basic requirements.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
62 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You must be between 18 and 55 years old, with a body mass index (BMI) from 18 to 29.
  • You must agree to use effective birth control if you or your partner can become pregnant.
  • You must have a negative pregnancy test (if female).
  • You must not be pregnant or breastfeeding.
  • You must not have a history of alcohol or drug abuse.
  • You must not have taken any other experimental drugs in the last 30 days.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07413536Not yet recruiting· Phase 1
Healthy volunteer study of a new injection (EB070) given under the skin

This trial tests a single dose of an experimental medicine called EB070 in healthy people. It checks how the drug moves through the body and if it causes side effects. You may be able to join if you are a generally healthy adult.

NCT07640269Not yet recruiting· Phase 1
Safety Study of New Drug ATH-097 in Healthy Adults

This is an early-stage safety study testing a new experimental drug called ATH-097 in healthy volunteers. Researchers will give increasing doses to small groups to learn how the drug is tolerated and processed by the body.

Melbourne, Victoria
NCT06612970Recruiting· Phase 1
Single dose study of HB0056 in healthy adults

This trial tests a single dose of a new medicine called HB0056 in healthy volunteers to evaluate its safety and how the body processes it. If you are a healthy adult, you may help doctors understand if this drug is safe for future studies.

Christchurch
NCT06867796Not yet recruiting· Phase 1
Safety study of TL-001 in healthy adults

This trial tests a new drug, TL-001, in healthy volunteers to see if it is safe and how the body processes it. You may join if you are a healthy adult between 18 and 55.

NCT07281703Recruiting· Phase 1
Safety study of HY8931 in healthy adults

This study tests a new oral medication, HY8931, in healthy adults to see if it is safe and how the body processes it. You will be closely monitored during the trial.

Brisbane
NCT07099118Recruiting· Phase 1
Safety and tolerability of HEC169584 in healthy people

This early-stage study checks if a new medicine called HEC169584 is safe for people and how it moves through the body. It looks for healthy volunteers to take part.

Beijing, Beijing Municipality

Hear when a new Hepatitis E trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.